Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Rxsight Inc
(NQ:
RXST
)
47.41
+0.64 (+1.37%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Rxsight Inc
< Previous
1
2
3
Next >
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
July 16, 2024
Johnson & Johnson has beaten earnings per share in more than 10 straight quarters. Will the trend continue in Q2?
Via
Benzinga
RxSight Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
July 15, 2024
Via
Benzinga
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 10, 2024
Via
Benzinga
Why RxSight (RXST) Shares Are Falling
May 09, 2024
RxSight shares are trading lower by 5.6% during Thursday's session. The company announced pricing of its $100 million proposed public offering of common stock.
Via
Benzinga
What 10 Analyst Ratings Have To Say About RxSight
May 07, 2024
Via
Benzinga
Assessing RxSight: Insights From 8 Financial Analysts
April 11, 2024
Via
Benzinga
Forecasting The Future: 9 Analyst Projections For RxSight
February 29, 2024
Via
Benzinga
Do You Have Your Eye On Vision Care Stocks?
May 20, 2024
For investors seeking stable and growing opportunities, eye care stocks are an attractive option.
Via
Talk Markets
RXST Stock Earnings: RxSight Beats EPS, Beats Revenue for Q1 2024
May 06, 2024
RXST stock results show that RxSight beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
May 06, 2024
Via
Benzinga
Chart Of The Day: RxSight - Cashing In On Cataracts
March 04, 2024
Earnings are estimated to increase 33.30% this year, increase an additional 26.60% next year and continue to compound at an annual rate of 19.00% for the next 5 years
Via
Talk Markets
Recap: RxSight Q4 Earnings
February 28, 2024
Via
Benzinga
Jim Cramer: This Healthcare Stock Is 'Too Risky,' But Shares Jumped 64% Over Past Month
January 25, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is "too risky."
Via
Benzinga
Breaking Down RxSight: 5 Analysts Share Their Views
January 08, 2024
Via
Benzinga
Analyst Expectations for RxSight's Future
December 13, 2023
Via
Benzinga
RxSight: Q3 Earnings Insights
November 09, 2023
Via
Benzinga
Earnings Scheduled For February 28, 2024
February 28, 2024
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.
Via
Benzinga
RxSight's Earnings Outlook
February 27, 2024
Via
Benzinga
Stifel Maintains Buy Rating for RxSight: Here's What You Need To Know
February 12, 2024
Via
Benzinga
The Analyst Landscape: 8 Takes On RxSight
January 29, 2024
Via
Benzinga
Where RxSight Stands With Analysts
August 08, 2023
Via
Benzinga
3 Stocks to Buy BEFORE They Become Household Names
January 12, 2024
The best way to find 100 baggers is to invest in undiscovered stock gems that have yet to become household names.
Via
InvestorPlace
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 08, 2024
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...
Via
Benzinga
RxSight's Earnings: A Preview
August 04, 2023
Via
Benzinga
The Latest Analyst Ratings for RxSight
July 12, 2023
Via
Benzinga
Analyst Expectations for RxSight's Future
April 13, 2023
Via
Benzinga
Looking Into RxSight's Return On Capital Employed
March 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 08, 2023
Via
Benzinga
RxSight Is A Potential Acquisition Target: Analyst Highlights How LAL Revenue Mix Could Drive Share Price To $45+
July 12, 2023
Needham analyst David Saxon reiterated a Buy rating on RxSight, Inc. (NASDAQ: RXST),
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2023
April 13, 2023
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.